PrimeRFP SCOUT · Federal Contract Recompete Brief

36C24226D0007NEW JERSEY CHEMO compounding — Optum Infusion Services 308, LLC

Optum Infusion Services 308, LLC holds $3.6M across 17 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards in the incumbent pipeline. Set-aside status: NONE.

242-Network Contract Office 02 (36C242)

Awarding office

Optum Infusion Services 308, LLC

Recipient

—

Estimated value

6505

PSC

NONE

Set-aside

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Optum Infusion Services 308, LLC — $90

Contract facts

NONE

Contract number36C24226D0007

Also listed as36C242-26-D-0007

Agency242-Network Contract Office 02 (36C242)

Awarding office242-Network Contract Office 02 (36C242)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentOptum Infusion Services 308, LLC

UEIRN5UVE9XMJN4

PSC6505

NEW JERSEY CHEMO COMPOUNDING is a federal NONE award for 242-Network Contract Office 02 (36C242) held by Optum Infusion Services 308, LLC. Estimated value —.

Incumbent footprint

Public record

Optum Infusion Services 308, LLC — $3.6M obligated across 17 awards (firm-wide, all agencies).

Sole agency: Department of Veterans Affairs (VA)

Department of Veterans Affairs (VA)$3.6M · 100% of firm total

Open full company profile →

Related awards

Same incumbent

36C24226N0119

CHEMO COMPOUNDING

$1.6M

Sep 30, 2026

36C25626N0215

HAZARDOUS COMPOUNDING SERVICES

$300K

Sep 30, 2026

36C25726N0093

AMARILLO VA PHARMACY COMPOUNDING FOR ONCOLOGY MEDICATIONS

$225K

Oct 31, 2026

36C25626N0560

CONTINGENCY MEDICATION COMPOUNDING SERVICES - EO 14398

$500K

May 6, 2027

36C24526P0129

IV SUPPORT

$300K

Aug 26, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C24226D0007?

36C24226D0007 (NEW JERSEY CHEMO compounding) is a 242-Network Contract Office 02 (36C242) award with an estimated value of —, currently held by Optum Infusion Services 308, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C242-26-D-0007?

36C242-26-D-0007 is the dashed form of PIID 36C24226D0007 (NEW JERSEY CHEMO compounding), held by Optum Infusion Services 308, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C24226D0007?

242-Network Contract Office 02 (36C242) awarded 36C24226D0007 to Optum Infusion Services 308, LLC.

Who is the incumbent on 36C24226D0007?

Optum Infusion Services 308, LLC is the incumbent with $3.6M across 17 related awards in SCOUT’s public footprint.

When does Optum Infusion Services 308, LLC’s 36C24226D0007 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 36C24226D0007 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthly